Dados B3 › BRFS3 × ABEV3
BRFS3 × ABEV3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | BRFS3 | ABEV3 | year |
|---|---|---|---|
| ROE | 23.2% | 16.6% | 2025 |
| ROIC | 19.5% | 26.6% | 2025 |
| ROA | 5.0% | 10.4% | 2025 |
| Gross margin | 25.2% | 51.4% | 2025 |
| EBIT margin | 10.2% | 26.5% | 2025 |
| Net margin | 5.1% | 18.1% | 2025 |
| Net debt/EBITDA | 1.42x | -0.56x | 2025 |
| Current ratio | 1.36x | 0.96x | 2025 |
| Revenue growth (1y) | 6.0% | -1.4% | 2025 |
| Revenue growth (5y CAGR) | 10.5% | 8.6% | 2025 |
| Piotroski F-Score | 4/9 | 6/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | BRFS3 | ABEV3 | year |
|---|---|---|---|
| P/E | 9.59x | 16.64x | 2024 × 2025 |
| P/B | 2.04x | 2.93x | 2024 × 2025 |
| EV/EBITDA | 3.81x | 7.97x | 2024 × 2025 |
| FCF yield | 31.8% | 7.7% | 2024 × 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:42 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:42 UTC. If this does not match /saude, you are reading a cached copy.